DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Diclofensine
Diclofensine
(19) United States (12) Patent Application Publication (10) Pub
2012 Harmonized Tariff Schedule Pharmaceuticals Appendix
Dopamine Transporter DAT; SLC6A3
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Antidepressant Treatment for Postnatal Depression
Duloxetine Increases Serotonin and Norepinephrine Availability in Healthy Subjects: a Double-Blind, Controlled Study
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Rana Dadashova
Datasheet Inhibitors / Agonists / Screening Libraries a DRUG SCREENING EXPERT
Download Product Insert (PDF)
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
Bupropion Perceived As a Stimulant by Two Patients with a Previous History of Cocaine Misuse
CCDAN Search Strategies (All Antidepressants)
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS)
Top View
Neurobilolgical Models for Evaluating Mechanisms Underlying Cocaine Addiction
Substance Abuse in the Workplaces of Our Bodies and Mind
(12) Patent Application Publication (10) Pub. No.: US 2010/0226943 A1 Brennan Et Al
(12) United States Patent (10) Patent No.: US 9,173,879 B2 Wei Et Al
WO 2016/135707 Al 1 September 2016 (01.09.2016) P O P C T
Table [1]: Definition of Reported Outcomes Study Outcome
Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: a Content Analysis
An Investigation of Bupropion Substitution for the Interoceptive Stimulus Effects of Nicotine Jamie L
Pharmaceutical Appendix to the Tariff Schedule 2
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
(12) STANDARD PATENT (11) Application No. AU 2019203887 B2 (19) AUSTRALIAN PATENT OFFICE
Diclofensine | Medchemexpress
Impact of Attention-Deficit/Hyperactivity Disorder Medications" (2007)
Monoamine Transporter and Receptor Interaction Profiles in Vitro Predict
Schedule Clxxiii - European Union
A CLINICAL PHARMACOLOGICAL COMPARISON of DICLOFENSINE (Ro 8-4650) with NOMIFENSINE and AMITRIPTYLINE in NORMAL HUMAN VOLUNTEERS J